ANN ARBOR, Mich., March 07, 2018 -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will present at the 30th Annual ROTH Conference on March 13, 2018 in Dana Point, CA.
Chief Executive Officer Gerald Solensky, Jr. will provide an overview of Zomedica’s business during his live presentation and will be available to participate in one-on-one meetings with investors registered to attend the conference.
30th Annual ROTH Conference
Date: Tuesday, March 13, 2018
Time: 2:30 p.m. PDT
Location: The Ritz-Carlton Laguna Nigel, Dana Point, CA
Investors and other interested parties will be able to access a live webcast of the presentation by visiting Zomedica’s website at http://investors.zomedica.com. A replay of the webcast will be accessible on the Zomedica website following the event.
About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) (TSX-V:ZOM) is a veterinary diagnostic and pharmaceutical and company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.
Follow Zomedica
- Email Alerts: http://investors.zomedica.com
- LinkedIn: https://www.linkedin.com/company/zomedica
- Facebook: https://www.facebook.com/zomedica/
- Twitter: https://twitter.com/zomedica
Reader Advisory
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.
Investor Relations Contacts
Shameze Rampertab, CPA, CA
[email protected]
+1 647.283.3630
PCG Advisory Group
Kirin Smith, COO
[email protected]
+1 646.863.6519
www.pcgadvisory.com
Media Contact
Andrea Eberle
[email protected]
+1 734.369.2555


GSM Eyes US, Europe Expansion Ahead of 2028 Hong Kong IPO
CATL Shares Fall as Hungary Plant Faces Safety Halt
Qantas Near-Miss Raises Sydney Air Traffic Controller Fatigue Concerns
Lynas Rare Earths Shares Rise After Takeover Talks Revealed
OpenAI Rejects Apple Trade Secret Theft Claims
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability
Anthropic Nears $15 Billion Credit Deal Ahead of IPO
OpenAI Nears Astra AI Model Launch With Safety Focus
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies
Milei Threatens Falkland Oil Firms With Sanctions
ByteDance Secures $29.6 Billion Loan to Boost AI Investment
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab
Xiaomi Shares Jump on Europe EV Expansion Plan 



